Copyright Reports & Markets. All rights reserved.

Global Cardiac Biomarker Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cardiac Biomarker Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cardiac Biomarker Market Size Growth Rate by Product
      • 1.4.2 Creatine kinase (CK) MB
      • 1.4.3 Troponin (cTnI and cTnT)
      • 1.4.4 BNP & NT-proBNP
      • 1.4.5 Myogloblin
      • 1.4.6 Others (hs-CRP, D-Dimer, etc.)
    • 1.5 Market by End User
      • 1.5.1 Global Cardiac Biomarker Market Size Growth Rate by End User
      • 1.5.2 Myocardial Infarction
      • 1.5.3 Congestive Heart Failure
      • 1.5.4 Acute Coronary Syndrome
      • 1.5.5 Atherosclerosis
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cardiac Biomarker Market Size
      • 2.1.1 Global Cardiac Biomarker Revenue 2014-2025
      • 2.1.2 Global Cardiac Biomarker Sales 2014-2025
    • 2.2 Cardiac Biomarker Growth Rate by Regions
      • 2.2.1 Global Cardiac Biomarker Sales by Regions
      • 2.2.2 Global Cardiac Biomarker Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cardiac Biomarker Sales by Manufacturers
      • 3.1.1 Cardiac Biomarker Sales by Manufacturers
      • 3.1.2 Cardiac Biomarker Sales Market Share by Manufacturers
      • 3.1.3 Global Cardiac Biomarker Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cardiac Biomarker Revenue by Manufacturers
      • 3.2.1 Cardiac Biomarker Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cardiac Biomarker Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cardiac Biomarker Price by Manufacturers
    • 3.4 Cardiac Biomarker Manufacturing Base Distribution, Product Types
      • 3.4.1 Cardiac Biomarker Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cardiac Biomarker Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cardiac Biomarker Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cardiac Biomarker Sales by Product
    • 4.2 Global Cardiac Biomarker Revenue by Product
    • 4.3 Cardiac Biomarker Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cardiac Biomarker Breakdown Data by End User

    6 North America

    • 6.1 North America Cardiac Biomarker by Countries
      • 6.1.1 North America Cardiac Biomarker Sales by Countries
      • 6.1.2 North America Cardiac Biomarker Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cardiac Biomarker by Product
    • 6.3 North America Cardiac Biomarker by End User

    7 Europe

    • 7.1 Europe Cardiac Biomarker by Countries
      • 7.1.1 Europe Cardiac Biomarker Sales by Countries
      • 7.1.2 Europe Cardiac Biomarker Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cardiac Biomarker by Product
    • 7.3 Europe Cardiac Biomarker by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cardiac Biomarker by Countries
      • 8.1.1 Asia Pacific Cardiac Biomarker Sales by Countries
      • 8.1.2 Asia Pacific Cardiac Biomarker Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cardiac Biomarker by Product
    • 8.3 Asia Pacific Cardiac Biomarker by End User

    9 Central & South America

    • 9.1 Central & South America Cardiac Biomarker by Countries
      • 9.1.1 Central & South America Cardiac Biomarker Sales by Countries
      • 9.1.2 Central & South America Cardiac Biomarker Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cardiac Biomarker by Product
    • 9.3 Central & South America Cardiac Biomarker by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cardiac Biomarker by Countries
      • 10.1.1 Middle East and Africa Cardiac Biomarker Sales by Countries
      • 10.1.2 Middle East and Africa Cardiac Biomarker Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cardiac Biomarker by Product
    • 10.3 Middle East and Africa Cardiac Biomarker by End User

    11 Company Profiles

    • 11.1 Alere
      • 11.1.1 Alere Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Alere Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Alere Cardiac Biomarker Products Offered
      • 11.1.5 Alere Recent Development
    • 11.2 Roche Diagnostics
      • 11.2.1 Roche Diagnostics Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Roche Diagnostics Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Roche Diagnostics Cardiac Biomarker Products Offered
      • 11.2.5 Roche Diagnostics Recent Development
    • 11.3 BG Medicine
      • 11.3.1 BG Medicine Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 BG Medicine Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 BG Medicine Cardiac Biomarker Products Offered
      • 11.3.5 BG Medicine Recent Development
    • 11.4 Biomerieux
      • 11.4.1 Biomerieux Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Biomerieux Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Biomerieux Cardiac Biomarker Products Offered
      • 11.4.5 Biomerieux Recent Development
    • 11.5 Critical Diagnostics
      • 11.5.1 Critical Diagnostics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Critical Diagnostics Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Critical Diagnostics Cardiac Biomarker Products Offered
      • 11.5.5 Critical Diagnostics Recent Development
    • 11.6 DiaDexus
      • 11.6.1 DiaDexus Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 DiaDexus Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 DiaDexus Cardiac Biomarker Products Offered
      • 11.6.5 DiaDexus Recent Development
    • 11.7 Response Biomedical
      • 11.7.1 Response Biomedical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Response Biomedical Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Response Biomedical Cardiac Biomarker Products Offered
      • 11.7.5 Response Biomedical Recent Development
    • 11.8 Siemens Healthcare
      • 11.8.1 Siemens Healthcare Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Siemens Healthcare Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Siemens Healthcare Cardiac Biomarker Products Offered
      • 11.8.5 Siemens Healthcare Recent Development
    • 11.9 Singulex
      • 11.9.1 Singulex Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Singulex Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Singulex Cardiac Biomarker Products Offered
      • 11.9.5 Singulex Recent Development
    • 11.10 Thermo Scientific
      • 11.10.1 Thermo Scientific Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Thermo Scientific Cardiac Biomarker Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Thermo Scientific Cardiac Biomarker Products Offered
      • 11.10.5 Thermo Scientific Recent Development

    12 Future Forecast

    • 12.1 Cardiac Biomarker Market Forecast by Regions
      • 12.1.1 Global Cardiac Biomarker Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cardiac Biomarker Revenue Forecast by Regions 2019-2025
    • 12.2 Cardiac Biomarker Market Forecast by Product
      • 12.2.1 Global Cardiac Biomarker Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cardiac Biomarker Revenue Forecast by Product 2019-2025
    • 12.3 Cardiac Biomarker Market Forecast by End User
    • 12.4 North America Cardiac Biomarker Forecast
    • 12.5 Europe Cardiac Biomarker Forecast
    • 12.6 Asia Pacific Cardiac Biomarker Forecast
    • 12.7 Central & South America Cardiac Biomarker Forecast
    • 12.8 Middle East and Africa Cardiac Biomarker Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cardiac Biomarker Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Cardiac Biomarker market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Biomarker market based on company, product type, end user and key regions.

      This report studies the global market size of Cardiac Biomarker in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Biomarker in these regions.
      This research report categorizes the global Cardiac Biomarker market by top players/brands, region, type and end user. This report also studies the global Cardiac Biomarker market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Alere
      Roche Diagnostics
      BG Medicine
      Biomerieux
      Critical Diagnostics
      DiaDexus
      Response Biomedical
      Siemens Healthcare
      Singulex
      Thermo Scientific

      Market size by Product
      Creatine kinase (CK) MB
      Troponin (cTnI and cTnT)
      BNP & NT-proBNP
      Myogloblin
      Others (hs-CRP, D-Dimer, etc.)
      Market size by End User
      Myocardial Infarction
      Congestive Heart Failure
      Acute Coronary Syndrome
      Atherosclerosis
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cardiac Biomarker market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cardiac Biomarker market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cardiac Biomarker companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cardiac Biomarker submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cardiac Biomarker are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Biomarker market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now